Politics
Stock
Investing
Business

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

admin

previous post

Operational Update

next post

UAE AMBASSADOR YOUSEF AL OTAIBA: US and UAE forge groundbreaking high-tech partnership based on AI

You may also like

Crypto Market Recap: Strategy Eyes US$1 Billion Capital...

June 7, 2025

Ford Government Pushes Bill 5 Through Legislature, Sparking...

June 7, 2025

Hempalta Provides Strategic Update Regarding Equipment Sale and...

June 7, 2025

Editor’s Picks: Marathon Project Gets Nod, Rio Tinto...

June 7, 2025

Top 5 Canadian Mining Stocks This Week: Africa...

June 7, 2025

Justin Huhn: Uranium Game On — Supply “Mirage,”...

June 6, 2025

Should You Invest in Silver Bullion?

June 6, 2025

Trump Admin Strips “Safety” from AI Oversight Institute...

June 6, 2025

In-fill RC Drilling at Kamperman Confirms High-Grade Gold

June 6, 2025

Offer Booklet – Non-Renounceable Entitlement Offer

June 6, 2025

Copyright © 2025 trustedgoldreserve.com | All Rights Reserved

Stock

Week Ahead: NIFTY’s Behavior Against This Level Crucial As The Index Looks At Potential Resumption Of An Upmove

June 7, 2025
From Tariffs to Tech: Where Smart Money’s Moving Right Now

June 7, 2025
Your Weekly Stock Market Snapshot: What It Means for Your Investments

June 7, 2025
Big Rally Ahead Should Yield All-Time High on This Index

June 7, 2025
Everyone Talks About Leaving a Better Planet for Our Children: Why Don’t We Leave Better Children for Our Planet?

June 7, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 trustedgoldreserve.com | All Rights Reserved

Politics
Stock
Investing
Business